Imaginatik PLC
09 February 2007
Imaginatik plc
('Imaginatik' or the 'Company')
Appointment of UK Managing Director
Imaginatik plc (AIM: IMTK), a leading provider of business innovation and
technology based systems for innovation and idea management, announces today the
appointment of Mr. Geoff Carss as UK Managing Director with additional
responsibility of the Company's strategic partner programme. This is a senior
management appointment rather than Board position.
Reporting to the Board of Imaginatik, Geoff, aged 45, brings a high level of
business development expertise and industry contacts following 12 years in the
consultancy and technology industries. His previous appointments include partner
for the public sector at IBM Business Consulting Services, as well as senior
positions at Compaq Computers, Hedra plc and Ernst & Young.
The appointment follows Imaginatik's successful flotation in December last year,
where the Company raised £1.5m net of expenses to fund its expansion into
developing markets, including the UK and Europe. The Company has an established
client base in the US, ranging across a number of industry sectors, and is
seeing significant growth in its business. Clients of Imaginatik include Pfizer
Inc., Hewlett-Packard, Weyerhaeuser Corporation, Chevron, Texaco Global
Lubricants and Cargill Inc.
Mark Turrell, Chief Executive of Imaginatik commented, 'We are delighted that
Geoff is joining the Imaginatik team. He will be instrumental in driving sales
in the UK as well as managing and developing our UK and European partner
programme, enabling us to take advantage of the rapidly growing market for
innovation solutions.'
Further enquiries
Imaginatik plc Tel: 020 7917 2975
Mark Turrell, CEO / Shawn Taylor, CFO
ICIS Tel: 020 7651 8688
Tom Moriarty / Caroline Evans-Jones
About Imaginatik
Imaginatik is a leading provider of innovation infrastructure to some of the
world's leading companies. More than 110 clients rely on Imaginatik's software,
consulting and research to enable their best-of-breed Innovation activities.
Imaginatik's software and consulting services have helped clients discover
significant sources of additional revenue, as well as tangible cost savings,
process improvements and increased product pipeline. Imaginatik is also
committed to developing strategic solutions in the field of innovation, working
with academic institutions such as the London Business School and the Cass
School of Business, London, as well as leading practitioners of corporate
innovation.
Imaginatik was admitted to trading on AIM on 15 December 2006, raising £1.5m net
of expenses.
For further information please visit www.imaginatik.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.